ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,076	1,052	656	771	348	733
Market Cap Growth	6.12%	60.42%	-14.98%	121.46%	-52.48%	38.82%
Enterprise Value	1,580	1,175	913	966	535	868
Last Close Price	55.10	55.14	40.23	46.08	29.04	61.67
PE Ratio	-	64.76	-	-	-	123.34
Forward PE	10.41	14.04	14.79	12.86	7.15	13.32
PS Ratio	1.91	2.16	2.07	3.57	1.67	3.55
PB Ratio	2.66	2.30	1.94	2.15	1.78	3.44
P/TBV Ratio	-	5.38	19.39	64.94	96.52	25.43
P/FCF Ratio	14.01	9.56	-	1008.43	38.15	18.80
P/OCF Ratio	11.58	8.85	-	232.22	22.82	16.06
PEG Ratio	1.02	1.02	1.02	1.02	-	6.06
EV/Sales Ratio	2.84	2.41	2.89	4.47	2.57	4.20
EV/EBITDA Ratio	19.24	10.75	18.78	50.64	18.40	14.22
EV/EBIT Ratio	72.46	23.73	-	-	-	52.86
EV/FCF Ratio	20.58	10.67	-	1263.31	58.56	22.26
Debt / Equity Ratio	1.47	0.64	0.85	0.80	1.02	0.90
Debt / EBITDA Ratio	7.41	2.61	5.81	15.06	6.87	3.14
Debt / FCF Ratio	8.24	2.65	-	375.65	21.88	4.92
Asset Turnover	0.51	0.58	0.41	0.35	0.45	0.47
Inventory Turnover	1.75	1.68	1.43	1.41	1.60	1.42
Quick Ratio	1.84	2.63	2.15	2.61	1.32	2.18
Current Ratio	2.74	3.57	3.46	3.68	2.17	3.04
Return on Equity (ROE)	-1.60%	4.72%	-13.74%	-15.37%	-11.04%	2.97%
Return on Assets (ROA)	1.25%	3.72%	-0.90%	-2.86%	-2.12%	2.31%
Return on Capital (ROIC)	1.51%	4.50%	-1.08%	-3.38%	-2.43%	2.61%
Earnings Yield	-0.81%	1.78%	-7.30%	-5.52%	-6.47%	0.83%
FCF Yield	7.14%	10.46%	-6.11%	0.10%	2.62%	5.32%
Payout Ratio	0.00%	8.65%	-	-	-	-
Buyback Yield / Dilution	-10.09%	-11.89%	-29.09%	-5.28%	0.63%	-2.28%
Total Shareholder Return	-10.09%	-11.89%	-29.09%	-5.28%	0.63%	-2.28%

Source: S&P Capital IQ. Standard template. Financial Sources.